Walleye Capital’s CureVac CVAC Stock Holding History

Walleye Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$2.1K	–	5481
2023 Q4	$2.1K	Sell	500 -12,000	-96%	-$65.1K	﹤0.01%	4753
2023 Q3	$85.4K	Buy	+12,500	New	+$110K	﹤0.01%	4011

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's CVAC Position: Q3 2024 in Review

Walleye Capital sold out of CureVac (CVAC) in Q3 2024, closing a stake of 187,872 shares — an estimated $639K sold.

Walleye Capital first reported a position in CVAC in Q3 2023 and held it in 4 quarters. The position peaked at $3.23M in Q4 2023. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

Walleye Capital reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 187,872 CureVac shares in Q3 2024, an estimated $639K.
Walleye Capital first reported a position in CureVac in Q3 2023 and held it in 4 quarters.
Walleye Capital's CureVac position peaked at $3.23M in Q4 2023.
81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.